GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

Nicole Wright, from North Ayrshire, Scotland, wanted to lose weight before an upcoming vacation to Turkey. In August she ...

The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

November is Diabetes awareness month. Diabetes (Diabetes mellitus) is a common endocrine disorder in all mammals, dogs and cats included. Diabetes is characterized by a dysfunction of insulin ...

Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...